Inactive Instrument

Other languages A.P. Pharma, Inc. Other OTC

Equities

US00202J2033

End-of-day quote Other OTC Other stock markets
- ^USD	-

07-02	Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle	MT
07-02	Heron Therapeutics, Inc. Announces Acceptance of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle	07-02
Heron Therapeutics, Inc. Announces Acceptance of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle	07-02
Connect Biopharma Names New Chief Executive, Chair	06-12
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle	05-29
Heron Therapeutics, Inc. Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")	05-29
Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07
Heron Therapeutics, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	05-07
Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024	03-21
Sector Update: Health Care Stocks Slipping Late Afternoon	03-13
Heron Therapeutics Shares Soar After Q4 Results Beat	03-13
Heron Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-12
Heron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-12
Heron Therapeutics, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	03-12
Heron Therapeutics Says FDA Approved Expanded Label for Zynrelef to Add More Orthopedic, Soft Tissue Procedures	01-24
Heron Therapeutics, Inc. Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures	01-24
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday Amid Boeing 737 Max 9 Grounding	01-08
Heron Therapeutics Unveils Deal to Expand Sales Network for Postoperative Pain Control Anesthetic; Shares Rise Premarket	01-08
Heron Therapeutics, Inc. Enters into Five-Year Distributor Partnership with Crosslink Life Sciences, LLC to Expand the Sales Network Supporting ZYNRELEF	01-07
Kevin Kotler Resigns as A Member of the Board of Directors of Heron Therapeutics, Inc., Effective December 31, 2023	12-21
Heron Therapeutics Insider Bought Shares Worth $137,970, According to a Recent SEC Filing	11-17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages A.P. Pharma, Inc. Other OTC

Equities

US00202J2033

Other languages

Filters